Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e16863daa8a575940ff42ccfaf837784 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-61 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-61 |
filingDate |
2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-106074715-A |
titleOfInvention |
The pharmaceutical composition for the treatment of bladder cancer |
abstract |
The invention discloses a kind of pharmaceutical composition treating bladder cancer and preparation method thereof, pharmaceutical composition of the present invention is that proportioning forms with inokosterone, poly-algae, Eucalyptus fruit as crude drug, can make various dosage form by preparation process routinely, and treatment bladder cancer is evident in efficacy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106692261-A |
priorityDate |
2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |